ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

ClinicalTrials.gov ID: NCT03604978

Public ClinicalTrials.gov record NCT03604978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of Nivolumab Plus or Minus Ipilimumab in Combination With Multi-Fraction Stereotactic Radiosurgery for Recurrent High-Grade Radiation-Relapsed Meningioma

Study identification

NCT ID
NCT03604978
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
38 participants

Conditions and interventions

Interventions

  • Biospecimen Collection Procedure
  • Echocardiography Test Procedure
  • Ipilimumab Biological
  • Magnetic Resonance Imaging Procedure
  • Nivolumab Biological
  • Stereotactic Radiosurgery Radiation

Procedure · Biological · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 16, 2019
Primary completion
Mar 18, 2027
Completion
Mar 18, 2027
Last update posted
Apr 12, 2026

2019 – 2027

United States locations

U.S. sites
29
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
Mayo Clinic Hospital in Arizona Phoenix Arizona 85054
City of Hope Comprehensive Cancer Center Duarte California 91010
UC San Diego Moores Cancer Center La Jolla California 92093
Los Angeles General Medical Center Los Angeles California 90033
USC / Norris Comprehensive Cancer Center Los Angeles California 90033
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868
UCHealth University of Colorado Hospital Aurora Colorado 80045
UM Sylvester Comprehensive Cancer Center at Aventura Aventura Florida 33180
UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida 33146
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida 33442
Mayo Clinic in Florida Jacksonville Florida 32224-9980
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136
UM Sylvester Comprehensive Cancer Center at Kendall Miami Florida 33176
UM Sylvester Comprehensive Cancer Center at Plantation Plantation Florida 33324
University of Kansas Cancer Center Kansas City Kansas 66160
University of Kansas Hospital-Westwood Cancer Center Westwood Kansas 66205
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287
Mayo Clinic in Rochester Rochester Minnesota 55905
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141
Washington University School of Medicine St Louis Missouri 63110
University of Nebraska Medical Center Omaha Nebraska 68198
Laura and Isaac Perlmutter Cancer Center at NYU Langone New York New York 10016
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03604978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03604978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →